IMMUNE CHECKPOINT INHIBITOR
Clinical trials for IMMUNE CHECKPOINT INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new IMMUNE CHECKPOINT INHIBITOR trials appear
Sign up with your email to follow new studies for IMMUNE CHECKPOINT INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boost tested as new hope for tough kidney cancers
Disease control Recruiting nowThis study is testing whether adding a specialized form of radiation therapy can help control advanced kidney cancer that has started growing again after initial immunotherapy treatments. It will involve about 35 patients whose cancer has spread to multiple sites. The main goal i…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New combo therapy aims to stop aggressive liver Cancer's return
Disease control Recruiting nowThis study is for people who had surgery for liver cancer but are at high risk of it coming back. It compares two different follow-up treatments to see which is better at keeping the cancer away. One group gets a combination of targeted radiation and an immunotherapy drug. The ot…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Major trial tests Triple-Threat attack on advanced throat cancer
Disease control Recruiting nowThis large Phase 3 trial is testing whether adding a new immunotherapy drug (cadonilimab) and low-dose radiation to standard chemotherapy and radiation works better for people with newly diagnosed, advanced nasopharyngeal cancer. The study will compare the new combination to the …
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Blood test could predict cancer treatment success before scans show it
Knowledge-focused Recruiting nowThis study aims to find out if simple blood tests can predict how well patients with advanced cancers respond to immunotherapy drugs. Researchers will track 50 patients with late-stage lung, breast, colorectal, liver, or stomach cancer who are starting immunotherapy. They will co…
Matched conditions: IMMUNE CHECKPOINT INHIBITOR
Sponsor: Gene Solutions • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:56 UTC